EU General Court finds no genuine use of FEMIBION mark for pharmaceuticals 15 Dec 17
The EU General Court has annulled an EU Intellectual Property Office Board of Appeal decision, instead holding that registration of the EU word mark ‘FEMIBION’ does not cover pharmaceutical preparations and instead covers only dietetic substances.
This part of the website has now moved to the subscriber area. To read more, please pick an option below.
Register to access two articles per month
Subscribe for unlimited access to articles, in-depth analysis and research from the World Trademark Review experts
What our customers are saying
I look forward to reading the World Trademark Review e-mail updates every day. WTR provides a concise summary of noteworthy disputes and legislative issues around the world, as well as helpful country-specific overviews on trademark laws and practices.
Ruby A. Zefo
Director, Trademarks & Brands Legal
Subscribe to World Trademark Review to receive access to the full range of trademark intelligence, insight, and case law, as well as our guides, rankings and daily market insight delivered to your inbox.
Register for more free content
- Read more World Trademark Review blogs and articles
- Receive the editor's weekly review by email